|
2019-09-11 |
2019-09-09 |
B
Purchase
|
Velan Capital, L.P.
Large shareholder
|
72,023
+0.9%
4.99
USD 359,733
|
72,023
+0.9%
|
4.99
|
USD 359,733
|
|
|
2019-09-09 |
2019-09-09 |
B
Purchase
|
LTE Partners, LLC
Large shareholder
|
21,480
+1.1%
4.94
USD 106,096
|
21,480
+1.1%
|
4.94
|
USD 106,096
|
|
|
2019-09-09 |
2019-09-05 |
B
Purchase
|
LTE Partners, LLC
Large shareholder
|
43,520
+2.3%
4.62
USD 201,097
|
43,520
+2.3%
|
4.62
|
USD 201,097
|
|
|
2019-09-05 |
2019-09-04 |
B
Purchase
|
Velan Capital, L.P.
Large shareholder
|
243,614
+3.2%
4.51
USD 1,098,529
|
243,614
+3.2%
|
4.51
|
USD 1,098,529
|
|
|
2019-09-05 |
2019-09-03 |
B
Purchase
|
Velan Capital, L.P.
Large shareholder
|
277,424
+3.7%
4.39
USD 1,218,918
|
277,424
+3.7%
|
4.39
|
USD 1,218,918
|
|
|
2019-08-27 |
2019-08-26 |
B
Purchase
|
Velan Capital, L.P.
Large shareholder
|
73,230
+1.0%
4.30
USD 314,911
|
73,230
+1.0%
|
4.30
|
USD 314,911
|
|
|
2019-08-27 |
2019-08-23 |
B
Purchase
|
Velan Capital, L.P.
Large shareholder
|
130,826
+1.8%
4.31
USD 563,690
|
130,826
+1.8%
|
4.31
|
USD 563,690
|
|
|
2017-02-15 |
2017-02-15 |
S
Sale
|
Broadfin Healthcare Master Fund Ltd
Large shareholder
|
150,000
-2.1%
9.55
USD 1,432,500
|
150,000
-2.1%
|
9.55
|
USD 1,432,500
|
|
|
2017-02-15 |
2017-02-14 |
S
Sale
|
Broadfin Healthcare Master Fund Ltd
Large shareholder
|
150,000
-2.1%
9.68
USD 1,452,000
|
150,000
-2.1%
|
9.68
|
USD 1,452,000
|
|
|
2017-02-15 |
2017-02-14 |
S
Sale
|
Broadfin Healthcare Master Fund Ltd
Large shareholder
|
100,000
-1.4%
9.70
USD 970,000
|
100,000
-1.4%
|
9.70
|
USD 970,000
|
|
|
2017-02-15 |
2017-02-14 |
S
Sale
|
Broadfin Healthcare Master Fund Ltd
Large shareholder
|
50,000
-0.7%
9.70
USD 485,000
|
50,000
-0.7%
|
9.70
|
USD 485,000
|
|
|
2017-02-15 |
2017-02-14 |
S
Sale
|
Broadfin Healthcare Master Fund Ltd
Large shareholder
|
52,600
-0.7%
9.70
USD 510,220
|
52,600
-0.7%
|
9.70
|
USD 510,220
|
|
|
2017-02-15 |
2017-02-13 |
S
Sale
|
Broadfin Healthcare Master Fund Ltd
Large shareholder
|
100,000
-1.3%
9.70
USD 970,000
|
100,000
-1.3%
|
9.70
|
USD 970,000
|
|
|
2017-02-09 |
2017-02-09 |
S
Sale
|
Broadfin Healthcare Master Fund Ltd
Large shareholder
|
1,300
-0.0%
9.69
USD 12,591
|
1,300
-0.0%
|
9.69
|
USD 12,591
|
|
|
2017-02-09 |
2017-02-09 |
S
Sale
|
Broadfin Healthcare Master Fund Ltd
Large shareholder
|
100,000
-1.3%
9.66
USD 966,000
|
100,000
-1.3%
|
9.66
|
USD 966,000
|
|
|
2017-02-09 |
2017-02-09 |
S
Sale
|
Broadfin Healthcare Master Fund Ltd
Large shareholder
|
100,000
-1.3%
9.75
USD 975,000
|
100,000
-1.3%
|
9.75
|
USD 975,000
|
|
|
2017-02-09 |
2017-02-07 |
S
Sale
|
Broadfin Healthcare Master Fund Ltd
Large shareholder
|
50,000
-0.6%
9.65
USD 482,500
|
50,000
-0.6%
|
9.65
|
USD 482,500
|
|
|
2017-02-09 |
2017-02-07 |
S
Sale
|
Broadfin Healthcare Master Fund Ltd
Large shareholder
|
100,000
-1.3%
9.74
USD 974,000
|
100,000
-1.3%
|
9.74
|
USD 974,000
|
|
|
2015-06-15 |
2015-06-11 |
PS
Planned sale
|
ISRAEL ROBERT J
Executive Vice President, Medi
Officer
|
2,000
-5.4%
6.83
USD 13,660
|
2,000
-5.4%
|
6.83
|
USD 13,660
|
|
|
2015-03-16 |
2015-03-13 |
PS
Planned sale
|
ISRAEL ROBERT J
Executive Vice President, Medi
Officer
|
3,000
-7.9%
7.00
USD 21,000
|
3,000
-7.9%
|
7.00
|
USD 21,000
|
|
|
2015-03-13 |
2015-03-11 |
PS
Planned sale
|
ISRAEL ROBERT J
Executive Vice President, Medi
Officer
|
2,000
-5.4%
6.83
USD 13,660
|
2,000
-5.4%
|
6.83
|
USD 13,660
|
|
|
2015-03-04 |
2015-03-03 |
PS
Planned sale
|
ISRAEL ROBERT J
Executive Vice President, Medi
Officer
|
5,000
-12.5%
6.49
USD 32,450
|
5,000
-12.5%
|
6.49
|
USD 32,450
|
|
|
2015-01-13 |
2015-01-12 |
PS
Planned sale
|
ISRAEL ROBERT J
Executive Vice President, Medi
Officer
|
2,000
-5.4%
7.06
USD 14,112
|
2,000
-5.4%
|
7.06
|
USD 14,112
|
|
|
2014-12-12 |
2014-12-11 |
PS
Planned sale
|
ISRAEL ROBERT J
Executive Vice President, Medi
Officer
|
3,000
-7.9%
7.07
USD 21,201
|
3,000
-7.9%
|
7.07
|
USD 21,201
|
|
|
2014-11-21 |
2014-11-21 |
PS
Planned sale
|
ISRAEL ROBERT J
Executive Vice President, Medi
Officer
|
9,000
-20.4%
7.00
USD 63,000
|
9,000
-20.4%
|
7.00
|
USD 63,000
|
|
|
2014-11-14 |
2014-11-13 |
PS
Planned sale
|
ISRAEL ROBERT J
Executive Vice President, Medi
Officer
|
10,000
-22.2%
6.83
USD 68,300
|
10,000
-22.2%
|
6.83
|
USD 68,300
|
|
|
2014-11-12 |
2014-11-11 |
PS
Planned sale
|
ISRAEL ROBERT J
Executive Vice President, Medi
Officer
|
5,000
-12.5%
6.53
USD 32,650
|
5,000
-12.5%
|
6.53
|
USD 32,650
|
|
|
2014-07-23 |
2014-07-21 |
B
Purchase
|
Broadfin Healthcare Master Fund Ltd
Large shareholder
|
388,659
+4.5%
4.73
USD 1,838,357
|
388,659
+4.5%
|
4.73
|
USD 1,838,357
|
|
|
2014-07-23 |
2014-07-18 |
B
Purchase
|
Broadfin Healthcare Master Fund Ltd
Large shareholder
|
388,200
+4.7%
4.73
USD 1,836,186
|
388,200
+4.7%
|
4.73
|
USD 1,836,186
|
|
|
2014-07-23 |
2014-07-17 |
B
Purchase
|
Broadfin Healthcare Master Fund Ltd
Large shareholder
|
436,884
+5.6%
4.48
USD 1,957,240
|
436,884
+5.6%
|
4.48
|
USD 1,957,240
|
|
|
2014-07-23 |
2014-07-16 |
B
Purchase
|
Broadfin Healthcare Master Fund Ltd
Large shareholder
|
411,693
+5.6%
4.48
USD 1,844,385
|
411,693
+5.6%
|
4.48
|
USD 1,844,385
|
|
|
2013-07-22 |
2013-07-18 |
PS
Planned sale
|
ISRAEL ROBERT J
Senior VP Medical Affairs
Officer
|
5,000
-12.5%
6.33
USD 31,650
|
5,000
-12.5%
|
6.33
|
USD 31,650
|
|
|
2013-03-28 |
2013-03-27 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
100
+0.1%
5.36
USD 536
|
100
+0.1%
|
5.36
|
USD 536
|
|
|
2013-03-28 |
2013-03-27 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
50
+0.0%
5.34
USD 267
|
50
+0.0%
|
5.34
|
USD 267
|
|
|
2013-02-28 |
2013-02-27 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
227
+0.1%
2.75
USD 624
|
227
+0.1%
|
2.75
|
USD 624
|
|
|
2013-02-28 |
2013-02-27 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
535
+0.3%
2.72
USD 1,455
|
535
+0.3%
|
2.72
|
USD 1,455
|
|
|
2013-01-23 |
2013-01-22 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
315
+0.2%
2.83
USD 891
|
315
+0.2%
|
2.83
|
USD 891
|
|
|
2012-11-30 |
2012-11-28 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
7
+0.0%
2.14
USD 15
|
7
+0.0%
|
2.14
|
USD 15
|
|
|
2012-11-30 |
2012-11-28 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
1,000
+0.6%
2.13
USD 2,130
|
1,000
+0.6%
|
2.13
|
USD 2,130
|
|
|
2012-11-30 |
2012-11-28 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
100
+0.1%
2.13
USD 213
|
100
+0.1%
|
2.13
|
USD 213
|
|
|
2012-11-30 |
2012-11-28 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
100
+0.1%
2.13
USD 213
|
100
+0.1%
|
2.13
|
USD 213
|
|
|
2012-11-30 |
2012-11-28 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
100
+0.1%
2.12
USD 212
|
100
+0.1%
|
2.12
|
USD 212
|
|
|
2012-11-20 |
2012-11-19 |
B
Purchase
|
Baker Mark Robert
CEO
Executive Director
|
11,800
+8.2%
1.96
USD 23,104
|
11,800
+8.2%
|
1.96
|
USD 23,104
|
|
|
2012-11-19 |
2012-11-16 |
B
Purchase
|
Baker Mark Robert
CEO
Executive Director
|
49,793
+53.2%
1.82
USD 90,723
|
49,793
+53.2%
|
1.82
|
USD 90,723
|
|
|
2012-11-16 |
2012-11-15 |
B
Purchase
|
Baker Mark Robert
CEO
Executive Director
|
48,833
+108.9%
1.69
USD 82,332
|
48,833
+108.9%
|
1.69
|
USD 82,332
|
|
|
2012-07-03 |
2012-07-02 |
PS
Planned sale
|
ISRAEL ROBERT J
Senior VP Medical Affairs
Officer
|
1,000
-2.8%
9.79
USD 9,790
|
1,000
-2.8%
|
9.79
|
USD 9,790
|
|
|
2012-06-29 |
2012-06-27 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
100
+0.2%
9.29
USD 929
|
100
+0.2%
|
9.29
|
USD 929
|
|
|
2012-06-29 |
2012-06-27 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
179
+0.4%
9.29
USD 1,663
|
179
+0.4%
|
9.29
|
USD 1,663
|
|
|
2012-06-29 |
2012-06-27 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
21
+0.1%
9.27
USD 195
|
21
+0.1%
|
9.27
|
USD 195
|
|
|
2012-06-04 |
2012-06-01 |
PS
Planned sale
|
ISRAEL ROBERT J
Senior VP Medical Affairs
Officer
|
1,000
-2.5%
8.51
USD 8,508
|
1,000
-2.5%
|
8.51
|
USD 8,508
|
|
|
2012-05-03 |
2012-05-01 |
PS
Planned sale
|
ISRAEL ROBERT J
Senior VP Medical Affairs
Officer
|
1,000
-2.5%
10.93
USD 10,927
|
1,000
-2.5%
|
10.93
|
USD 10,927
|
|
|
2012-04-27 |
2012-04-25 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
100
+0.2%
9.92
USD 992
|
100
+0.2%
|
9.92
|
USD 992
|
|
|
2012-04-27 |
2012-04-25 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
100
+0.2%
9.97
USD 997
|
100
+0.2%
|
9.97
|
USD 997
|
|
|
2012-04-27 |
2012-04-25 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
15
+0.0%
10.25
USD 154
|
15
+0.0%
|
10.25
|
USD 154
|
|
|
2012-04-03 |
2012-04-02 |
PS
Planned sale
|
ISRAEL ROBERT J
Senior VP Medical Affairs
Officer
|
1,000
-2.5%
9.85
USD 9,852
|
1,000
-2.5%
|
9.85
|
USD 9,852
|
|
|
2012-03-29 |
2012-03-28 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
140
+0.3%
10.19
USD 1,427
|
140
+0.3%
|
10.19
|
USD 1,427
|
|
|
2012-03-29 |
2012-03-28 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
100
+0.2%
10.00
USD 1,000
|
100
+0.2%
|
10.00
|
USD 1,000
|
|
|
2012-03-02 |
2012-03-01 |
PS
Planned sale
|
ISRAEL ROBERT J
Senior VP Medical Affairs
Officer
|
1,000
-2.5%
9.82
USD 9,817
|
1,000
-2.5%
|
9.82
|
USD 9,817
|
|
|
2012-02-27 |
2012-02-23 |
PS
Planned sale
|
SCHEINBERG DAVID A
Non-Executive Director
|
1,250
-2.6%
10.00
USD 12,500
|
1,250
-2.6%
|
10.00
|
USD 12,500
|
|
|
2012-02-23 |
2012-02-22 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
1
+0.0%
9.54
USD 10
|
1
+0.0%
|
9.54
|
USD 10
|
|
|
2012-02-23 |
2012-02-22 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
100
+0.3%
9.45
USD 945
|
100
+0.3%
|
9.45
|
USD 945
|
|
|
2012-02-23 |
2012-02-22 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
2
+0.0%
9.42
USD 19
|
2
+0.0%
|
9.42
|
USD 19
|
|
|
2012-02-23 |
2012-02-22 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
100
+0.3%
9.40
USD 940
|
100
+0.3%
|
9.40
|
USD 940
|
|
|
2012-02-03 |
2012-02-03 |
S
Sale
|
BRINER KURT W
Non-Executive Director
|
33,000
-100.0%
10.22
USD 337,227
|
33,000
-100.0%
|
10.22
|
USD 337,227
|
|
|
2012-02-02 |
2012-02-01 |
PS
Planned sale
|
ISRAEL ROBERT J
Senior VP Medical Affairs
Officer
|
1,000
-2.5%
9.48
USD 9,478
|
1,000
-2.5%
|
9.48
|
USD 9,478
|
|
|
2012-01-26 |
2012-01-25 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
100
+0.3%
9.56
USD 956
|
100
+0.3%
|
9.56
|
USD 956
|
|
|
2012-01-26 |
2012-01-25 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
193
+0.5%
9.55
USD 1,843
|
193
+0.5%
|
9.55
|
USD 1,843
|
|
|
2012-01-26 |
2012-01-25 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
4
+0.0%
9.50
USD 38
|
4
+0.0%
|
9.50
|
USD 38
|
|
|
2012-01-26 |
2012-01-25 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
3
+0.0%
9.49
USD 28
|
3
+0.0%
|
9.49
|
USD 28
|
|
|
2012-01-26 |
2012-01-25 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
1
+0.0%
9.45
USD 9
|
1
+0.0%
|
9.45
|
USD 9
|
|
|
2012-01-12 |
2012-01-11 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
200
+0.5%
8.87
USD 1,774
|
200
+0.5%
|
8.87
|
USD 1,774
|
|
|
2012-01-12 |
2012-01-11 |
PP
Planned purchase
|
Baker Mark Robert
CEO
Executive Director
|
191
+0.5%
8.86
USD 1,692
|
191
+0.5%
|
8.86
|
USD 1,692
|
|
|
2012-01-04 |
2012-01-03 |
PS
Planned sale
|
ISRAEL ROBERT J
Senior VP Medical Affairs
Officer
|
1,000
-2.5%
8.78
USD 8,780
|
1,000
-2.5%
|
8.78
|
USD 8,780
|
|
|
2011-12-02 |
2011-12-01 |
PS
Planned sale
|
ISRAEL ROBERT J
Senior VP Medical Affairs
Officer
|
1,000
-2.5%
6.66
USD 6,660
|
1,000
-2.5%
|
6.66
|
USD 6,660
|
|
|
2011-11-01 |
2011-11-01 |
PS
Planned sale
|
ISRAEL ROBERT J
Senior VP Medical Affairs
Officer
|
1,000
-2.5%
6.33
USD 6,330
|
1,000
-2.5%
|
6.33
|
USD 6,330
|
|
